References
- Steffen R, Kane MA, Shapiro CN, Billo N, Schoellhorn KJ, van Damme Epidemiology and prevention of hepatitis A in travelers. JA/VIA 272,885–889 (1994).
- André F, Van Dame P, Safary A, Banatvala J. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use. Expert Rev Vaccines1(1), 9–23 (2002).
- •Discusses 10 years of clinical experience with inactivated hepatitis A vaccine.
- Safary A, André E Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 18,57–67 (2000).
- •Reviews 10 years of clinical experience with a recombinant hepatitis B vaccine.
- Abraham B, Baine Y, De-Clercq N etal. Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Res. 53(1), 63–73 (2002).
- •Absence of interference between hepatitis A and B antigens.
- Treadwell T Trends in travel. In: Principles and practices of travel medicine. Zuckerman J (Ed.), John Wiley & Sons Inc., UK (2001).
- Scoville SL, Bryan JP, Tribble D etal. Epidemiology, preventive services and illnesses of international travelers. Mil Med 162,172–178 (1997).
- Carson PJ, Nichol KL, O'Brien J, Hilo P, Janoff EN. Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern. Med 10, 160(13), 2017–2024 (2000).
- Paganelli R, Scala E, Quint I, Ansotegui IJ. Humoral immunity in aging. Aging al/Plano)6, 143–150 (1994).
- Treadwell T, Keeffe E, Lake J et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am.j Med 95(6), 584–588 (1993).
- Thoelen S, Van Damme P, Leentvaar—Kuypers A et al The first combined vaccine against hepatitis A and B: an overview. Vaccine 17(13-14), 1657–1662 (1999).
- •Review of pivotal data with Twinrixvaccine in Europe.
- Joines RVV, Blatter M, Abraham B et a/. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrixg) with corresponding monovalent vaccines (Havrix® and Engerix-B®) in adults. Vaccine 19,4710–4719 (2001).
- ••Review of pivotal data with Twimix vaccine in the USA.
- Delem A, Safary A, De Namur F, Hauser P, D'Hondt E. Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A. Vaccinell (4), 479–484 (1993).
- Hadler SC, Francis DP, Maynard JE et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl. Med. 315 (4), 209–214 (1986).
- Van Damme P, Leroux-Roels G, Law B et al. Long-term persistence of antibodies induced by vaccination and safety follow-up with the first combined vaccine against hepatitis A and B in children and adults. J. Med. Vino]. 65 (1), 6–13 (2001).
- •Long-term follow-up data with Twinrix in adults and children.
- Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine 10\(Suppl. 1), S138-141 (1992).
- Zaaijer HL, Leentvaar-Kuijpers A, Rotman H, Lelie PN. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. J. Med. Virol. 40(1), 22–27 (1993).
- Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines: implications for persons at occupational risk of hepatitis B virus infection. Am. J. Prey Med 15,1–8 (1998).
- Shaw FE Jr, Guess HA, Roets JM et al.. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 7(5), 425–430 (1989).
- Reuman PD, Kubilis P, Hurni W Brown L, Nalin D. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine 15 (10), 1157–61 (1997).
- Nalin DR, Kuter BJ, Brown L etal. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J. Hepatol. 18\(Suppl. 2), S51-55 (1993).
- Koff RS Immunogenicity of hepatitis B vaccines: implications of immune memory Vaccine 20,3695-3701(2002).
- •Review of imrnunogenicity data for several hepatitis B vaccines.
- Rendi-Wagner P, Kundi M, Stemberger H et al. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 19(15-16), 2055–2060 (2001).
- ••Comparative data with combined hepatitisA and B vaccine in a real-life situation.
- Keeffe EB. Vaccination against hepatitis A and B in chronic liver disease. Viral Hep. Rev 5(2), 77–88 (1999).
Websites
- Centers for Disease Control and Prevention. [www.cdc.govinccdphp/dnpa/ bmi/bmi-adult.html. Accessed November 2002.